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The stability and composition of the airway microbiome is an important determinant
of respiratory health. Some airway bacteria are considered to be beneficial due to
their potential to impede the acquisition and persistence of opportunistic bacterial
pathogens such as Streptococcus pneumoniae. Among such organisms, the presence
of Corynebacterium species correlates with reduced S. pneumoniae in both adults
and children, in whom Corynebacterium abundance is predictive of S. pneumoniae
infection risk. Previously, Corynebacterium accolens was shown to express a lipase
which cleaves host lipids, resulting in the production of fatty acids that inhibit growth
of S. pneumoniae in vitro. However, it was unclear whether this mechanism contributes
to Corynebacterium-S. pneumoniae interactions in vivo. To address this question, we
developed a mouse model for Corynebacterium colonization in which colonization
with either C. accolens or another species, Corynebacterium amycolatum, significantly
reduced S. pneumoniae acquisition in the upper airway and infection in the lung.
Moreover, the lungs of co-infected mice had reduced pro-inflammatory cytokines and
inflammatory myeloid cells, indicating resolution of infection-associated inflammation.
The inhibitory effect of C. accolens on S. pneumoniae in vivo was mediated by lipasedependent and independent effects, indicating that both this and other bacterial factors
contribute to Corynebacterium-mediated protection in the airway. We also identified
a previously uncharacterized bacterial lipase in C. amycolatum that is required for
inhibition of S. pneumoniae growth in vitro. Together, these findings demonstrate the
protective potential of airway Corynebacterium species and establish a new model
for investigating the impact of commensal microbiota, such as Corynebacterium, on
maintaining respiratory health.
Keywords: Corynebacterium, Streptococcus pneumoniae, nasopharyngeal colonization, lung infection,
pneumonia, pneumococcus, bacterial lipases
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Xu et al., 2021). Longitudinal studies tracking upper airway
microbiome dynamics in children over time indicate that
Corynebacterium abundance is predictive of both S. pneumoniae
carriage and risk of respiratory tract infection (Biesbroek et al.,
2014; Teo et al., 2015; Bosch et al., 2017; Kelly et al., 2021). Both
children and adults with a higher abundance of Corynebacterium
also have more stable airway microbiomes, compared to those
with a predominance of opportunistic pathogens including
S. pneumoniae (Bosch et al., 2017; Piters et al., 2019; Kelly et al.,
2021). Together, these studies indicate that Corynebacterium
species may play an important role in microbiome-mediated
protection against pathogens such as S. pneumoniae, thereby
reducing susceptibility to pneumonia.
Interruption of the potential protective benefit of
Corynebacterium species in the airway is of particular concern
for patients receiving antibiotics, as antibiotic therapy selectively
reduces the Corynebacterium population while pathogens
including S. pneumoniae are enriched (Teo et al., 2015;
Prevaes et al., 2016; Kelly et al., 2021). Mechanistically,
several Corynebacterium species can directly inhibit growth of
S. pneumoniae in vitro (Bomar et al., 2016; Kelly et al., 2021; Xu
et al., 2021). Among these, Corynebacterium accolens inhibits
S. pneumoniae growth by expression of a bacterial lipase called
LipS1, which hydrolyses host triacylglycerols, releasing free fatty
acids that kill S. pneumoniae (Bomar et al., 2016). Fatty acids
(FAs) are long-chain hydrocarbons with a terminal carboxyl
group which are a major component of lipids. Corynebacterium
species use fatty acids for growth, and lipophilic species including
C. accolens require exogenous lipids to survive (Bernard, 2012;
Tchoupa et al., 2021). Two non-lipophilic Corynebacterium
species, which do not require host lipids for growth, were
recently shown to inhibit S. pneumoniae in vitro, though the
mechanisms were not identified (Xu et al., 2021). Another nonlipophilic species, Corynebacterium amycolatum, is frequently
isolated from the human nasopharynx (Kaspar et al., 2016; Kelly
et al., 2021) but is unusual in that it lacks mycolic acid, a long
chain fatty acid which is a major component of the cell wall in
almost all other Corynebacterium (Collins et al., 1988; Marrakchi
et al., 2014). It is unclear whether FA production by bacterial
lipases are universally required for Corynebacterium-mediated
inhibition of S. pneumoniae, or whether diverse Corynebacterium
species, including those less dependent on exogenous lipids,
utilize similar mechanisms.
Understanding the host and bacterial requirements for
Corynebacterium-mediated protection against S. pneumoniae is
hampered by the lack of animal models for Corynebacterium
colonization. Two related studies employing a five-dose serial
inoculation of C. pseudodiphtheriticum in infant mice found that
this strategy improves protection against S. pneumoniae (Moyano
et al., 2020) as well as secondary pneumococcal infection in
Respiratory Syncytial Virus (RSV)-infected mice (Kanmani et al.,
2017). However, unknown is whether C. pseudodiphtheriticum
actually colonizes the infant mouse airway in this model or if
other Corynebacterium species can be used in a similar approach.
For this study, we developed a mouse model to investigate the
impact of two distinct species, C. accolens and C. amycolatum,
on protection against S. pneumoniae in vitro and in vivo. Our

INTRODUCTION
Respiratory tract infections are a prominent a global health
problem. Pneumonia, or lung infection, is a major source of
mortality as the 4th most common cause of death worldwide
(World Health Organization [WHO], 2021). Children are
particularly vulnerable, as pneumonia is the leading cause
of death in people under 5 years old (Centers for Disease
Control and Prevention, 2019). In the United States, over one
million emergency room visits are due to pneumonia every year
(Centers for Disease Control and Prevention, 2019). The most
common bacterial cause of pneumonia is the Gram-positive
bacterial pathogen Streptococcus pneumoniae, also known as
the pneumococcus (Jose et al., 2015; Torres et al., 2018).
S. pneumoniae vaccines are extremely effective against invasive
pneumococcal disease but are substantially less protective against
pneumococcal pneumonia (Cutts et al., 2005; Pilishvili and
Bennett, 2015), highlighting the need for new therapeutic
strategies to reduce the burden of disease. S. pneumoniae is
an opportunistic pathogen, as colonization in the nasopharynx
of the upper airway is asymptomatic and susceptibility to
infection differs among individuals. While this variation is not
completely understood, the composition and function of the
airway microbiome have emerged as important contributing
factors (Clark, 2020). The disruption of the airway microbiome
following antibiotic therapy correlates with an increased risk
of S. pneumoniae acquisition (Biesbroek et al., 2014; Teo
et al., 2015). Closely related Streptococcus commensals produce
factors such as bacteriocins that kill S. pneumoniae, and serial
administration of such commensals has shown some efficacy in
reducing the incidence of pneumococcal-associated infections
including otitis media in children (Marchisio et al., 2015;
La Mantia et al., 2017). However, the contributions of other
members of the commensal airway microbiome, particularly
non-streptococcal species, to protection against S. pneumoniae
are poorly understood.
Next-generation microbiome sequencing studies have
identified additional members of the airway microbiome which
are proposed to improve protection against pathogens including
S. pneumoniae. Carriage of Corynebacterium, frequently together
with Dolosigranulum, is associated with fewer upper and
lower respiratory tract infections in both children and adults
(Chonmaitree et al., 2017; Hasegawa et al., 2017; Copeland et al.,
2018; Lappan et al., 2018; Man et al., 2019). Corynebacterium
species are Gram-positive bacteria which frequently colonize
the skin and upper airway. While Corynebacterium diphtheriae,
the causative agent of diphtheria, is an important pathogen
(Bernard, 2012), other Corynebacterium species are rarely
associated with disease. Case reports have identified some
Corynebacterium species associated with pneumonia, most
frequently Corynebacterium pseudodiphtheriticum (Yang et al.,
2018), indicating opportunistic infections may occur. However,
non-C. diphtheriae species are more often associated with
respiratory health, as the abundance of Corynebacterium
species in nasopharynx correlates with reduced S. pneumoniae
colonization and infection in several studies (Laufer et al., 2011;
Pettigrew et al., 2012; Bomar et al., 2016; Kelly et al., 2017;
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37◦ C overnight with shaking at 200 rpm. OD600 was measured
to standardize starting inocula, and cultures were centrifuged
at ≥ 20,000 × g for 10 min to pellet bacterial cells. Cellfree supernatants (200 µL/plate) were spread onto TSB agar
plates containing neomycin 5 µg/mL, streptomycin 50 µg/mL
(streptomycinR strains), and fresh catalase (5,000 Units/plate)
and allowed to dry completely prior to S. pneumoniae serial
dilution plating. For the dose response curve, supernatants were
diluted in BHI broth (100–1.6% supernatant) prior to plating.
S. pneumoniae serial dilutions were completed in PBS, with 10 µL
spotted onto culture plates per dilution, plated in duplicate. Plates
were incubated at 37◦ C with 5% CO2 overnight for S. pneumoniae
CFU enumeration.

findings indicate that both C. accolens and C. amycolatum
can colonize the airways of antibiotic treated mice, and that
pre-exposure to these Corynebacterium species protects against
S. pneumoniae colonization of the upper airway as well as
infection and inflammation in the lung. We envision that this coinfection model can be used to further understand how exposure
to different Corynebacterium species in the airway influences
pneumococcal colonization and disease.

MATERIALS AND METHODS
Bacterial Strains
Corynebacterium accolens strain ATCC 49726TM was obtained
from the American Type Culture Collection. Corynebacterium
amycolatum strain SK46, HM-109 was obtained through BEI
Resources, NIAID, NIH as part of the Human Microbiome
Project. Corynebacterium strains were grown from glycerol stocks
on BHI agar plates (BD DifcoTM BactoTM Brain Heart Infusion,
Thermo Fisher Scientific) aerobically at 37◦ C overnight. Growth
from fresh plates was used to inoculate BHI broth cultures,
which were grown overnight aerobically at 37◦ C with shaking at
200 rpm in preparation for in vitro assays and in vivo infections.
BHI plates and broth were supplemented with 1% Tween 80
(polysorbate, VWR) to provide an exogenous lipid source, unless
otherwise specified. When indicated, 180 mg/mL triolein or oleic
acid (VWR) were added to plates or broth cultures.
Streptomycin resistant variants of Streptococcus pneumoniae
serotype 2 strain D39 and serotype 4 strain TIGR4 were kind gifts
from Dr. Jeffrey N. Weiser (New York University). S. pneumoniae
serotype 3 strain ATCC 6303TM from the American Type
Culture Collection was also used. S. pneumoniae was grown
in Todd Hewitt Broth supplemented with 5% Yeast Extract
(BD BactoTM ) and 50 µg/mL streptomycin (MilliporeSigma)
for streptomycinR strains. For all experiments, S. pneumoniae
cultures were grown from frozen stocks at 37◦ C with 5% CO2
without shaking to mid-log phase, centrifuged at ≥ 20,000 ×
g for 10 min, and resuspended in phosphate-buffered saline
(PBS). S. pneumoniae CFUs were determined by serial dilution
plating on Tryptic Soy Broth agar (TSB, MP Biomedicals)
supplemented with neomycin 5 µg/mL, streptomycin 50 µg/mL
(streptomycinR strains), and fresh catalase (5,000 Units/plate,
Worthington Biomedical Corporation Lakewood, NJ) at 37◦ C
with 5% CO2 overnight.
R

Construction of Corynebacterium
Mutant Strains
Mutation of the lipase encoding lipS1 in C. accolens was
performed as described previously (Bomar et al., 2016).
Briefly, ∼1 kb regions flanking the coding sequence region
for WP_005285206.1 in C. accolens ATCC 49726 (nucleotides
2,348,522–2,349,946) were amplified using Q5 high fidelity DNA
polymerase (NEB) with primers designed to add a 21 bp scar
sequence on the end of the 50 fragment and beginning of the
30 fragment, respectively, in addition to a stop codon at the
end of the 30 fragment (see Supplementary Table 1 for primer
sequences). PCR products were purified using the Monarch PCR
and DNA cleanup kit (NEB). We used the plasmid pKO (KAN)
as a suicide vector for lips1 cloning. pKO (KAN) was a gift from
Markus Seeger (Addgene #110086; RRID:Addgene_110086).1
pKO was digested with PstI and treated with calf intestinal
phosphatase according to manufacturer’s instructions (NEB)
and purified using the GeneJET plasmid miniprep kit (Thermo
Fisher Scientific). Purified plasmid and PCR products were
assembled by Gibson assembly using the HiFi DNA Assembly
Cloning Kit (NEB), and the assembled sequence was transformed
into high efficiency NEB 5-alpha competent E. coli (NEB).
Clones containing the assembly sequence inserted into pKO
were identified by sequencing (Quintara Biosciences, Hayward
CA). Competent cells of C. accolens were prepared and
pKO containing the lipS1 flanking regions was introduced by
electroporation as previously described for Corynebacterium
glutamicum (Eggeling et al., 2005). Electroporated cells were
resuspended in BHI Tween 80 broth containing sorbitol (9.1
g/100 mL) and heat shocked at 46◦ C for 6 min followed
by incubation at 37◦ C for 1 h prior to plating on selective
media. Transformants were grown on BHI agar supplemented
with Tween 80, sorbitol, and kanamycin 20 µg/mL to select
for clones which integrated the lipS1 flanking regions and
kanamycin resistance gene from the modified pKO plasmid
into the C. accolens genome by homologous recombination
(kanamycinR ) followed by 5% sucrose to select for clones which
lost the plasmid vector backbone (sucrose selection against sacB
in pKO). Deletions in lipS1 were confirmed by PCR amplification
and sequencing (Quintara Biosciences, Hayward CA). The same
process was used to construct an in-frame deletion in the

R

R

Inhibition of S. pneumoniae Growth by
Supernatant From Corynebacterium
Species
For supernatant inhibition assays, C. accolens and C. amycolatum
were grown on BHI agar supplemented with or without 1%
Tween 80 and 180 mg/mL triolein. Triolein was emulsified
in 100% ethanol for spreading onto plates, and plates were
dried to evaporate ethanol prior to inoculation. Plates were
incubated under aerobic conditions at 37◦ C overnight. Cultures
were inoculated from fresh plates in BHI broth with or without
1% Tween 80 and 180 mg/mL triolein and grown aerobically at
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coding sequence region for WP_005510233.1 in C. amycolatum
(nucleotides 16,770–17,957) using primers specific for the
flanking sequence regions (Supplementary Table 1).

Briefly, lungs were minced and digested with DNAseI (30
µg/mL, MilliporeSigma) and type 4 collagenase (1 mg/mL,
Worthington Biochemical Corporation). Lung preparations were
filtered with a 70 µM strainer prior to lysis of red blood
cells by brief (1 min) incubation in RBC lysis buffer (0.15M
NH4 Cl, 10 mM KHCO3, 0.1 mM Na2 EDTA, pH 7.4). Cell Fc
receptors were blocked with anti-CD16/32 2.4G2 hybridoma
supernatant prior to staining in FACS buffer (1% BSA, 0.01%
NaN3 in PBS). Cells were fixed in 1% paraformaldehyde.
Antibodies used included: Siglec F (clone E50-2440), MHCII
(clone M5/114.15.2), Ly6G (clone 1A8), Ly6C (clone HK1.4),
CD45.2 (clone 104), CD11c (clone N418), CD11b (clone M1/70),
CD64 (clone X54-5/7.1), and CD103 (clone 2E7). Antibodies
were purchased from eBioscience, BD, BioLegend, or Thermo
Fisher Scientific. Flow cytometry was performed using an LSRII
(BD) in the Rocky Mountain Regional VAMC Research Core,
Aurora CO and data were analyzed using FlowJoTM v10.8
Software (BD Life Sciences).

Animals
Male and female 6–12 week old C57BL/6J (WT) mice, purchased
from The Jackson Laboratory (RRID:IMSR_JAX:000664), were
bred in-house. Mouse colonies were maintained in the University
of Colorado Office of Laboratory Animal Resources.

Infections
All mice were treated with ingested broad-spectrum antibiotics
(ampicillin 1 g/L, neomycin 1 g/L, metronidazole 1 g/L,
vancomycin 0.5 g/L, MilliporeSigma and McKesson) ad libitum
for 7 days until 48 h prior to infection. Bacterial loads in
the stool pre- vs. post-antibiotic treatment were detected by
qPCR as described previously (Ricchi et al., 2017). Briefly,
stools were weighed and genomic DNA was extracted using the
PureLinkTM Genomic DNA Mini Kit (Thermo Fisher Scientific).
Quantitative PCR was performed using iTaqTM Universal SYBR
Green Supermix (BioRad) together with 200 nM forward and
reverse primers (Supplementary Table 1; Jimeno et al., 2018)
and 2.5 µL template DNA. Reactions were performed using
a CFX ConnectTM Real-Time System (BioRad) with cycling
conditions of: (1) 94◦ C for 4 min; (2) 40 cycles of 15 s at
95◦ C, 30 s at 60◦ C, and (3) 72◦ C for 10 min. A standard curve
was generated using a known concentration of S. pneumoniae
D39 gDNA, which together with the input ng/µL DNA and
Ct values was used to calculate total 16S rRNA gene copy
number as described previously (Gomes-Neto et al., 2017).
qPCR data was analyzed using CFX Manager Software (version
2.1, BioRad). Nasal lavages, which can only be collected upon
sacrifice, were obtained from separate groups of mice with and
without antibiotic treatment for quantification of bacterial load
by qPCR as above. Lavages were performed by the instillation of
200 µL PBS into cannulated trachea through the nasal cavity and
collected from the nares.
Mice were infected with C. accolens, C. amycolatum, and/or
S. pneumoniae, as indicated, at 107 CFU/mouse i.n. under
inhaled isoflurane anesthesia. Nasal lavages were collected as
above. Lungs were homogenized using a Bullet Blender tissue
homogenizer (Stellar Scientific, Baltimore, MD). S. pneumoniae
nasal lavage and lung CFUs were calculated following serial
dilution and growth on Tryptic Soy agar plates containing
neomycin (5 µg/mL, MilliporeSigma) and streptomycin (50
µg/mL, only streptomycinR strains), supplemented with
fresh catalase (5,000 Units/plate, Worthington Biochemical
Corporation, Lakewood, NJ) grown overnight at 37◦ C with
5% CO2 . Corynebacterium CFUs were calculated following
serial dilution and growth on BHI plates containing 1%
Tween 80 grown overnight aerobically at 37◦ C. In co-infected
mice, Corynebacterium CFUs were determined by subtracting
S. pneumoniae CFUs (on streptomycin plates) from total growth
(on non-selective BHI plates).
R

Cytokine and Chemokine Analysis
BAL cytokines and chemokines were measured using a
LEGENDplexTM Mouse Inflammation Panel, and data
were analyzed using the LEGENDplexTM Data Analysis
Software Suite (BioLegend). Analytes were detected on the LSR
Fortessa X-20 in the ImmunoMicro Flow Cytometry Shared
Resource Laboratory at the University of Colorado Anschutz
Medical Campus (RRID:SCR_021321). Serum cytokines
were measured using mouse TNFα and IFNγ ELISA kits
(BD), with analytes detected on a SynergyTM HT Microplate
Reader (BioTek).

Mass Spectrometry for Detection of
Fatty Acids
Samples were analyzed via ultra-high pressure liquid
chromatography coupled to mass spectrometry (UHPLC-MS)
at the University of Colorado School of Medicine Metabolomics
Core. Nasal lavages were vigorously vortexed to homogenize,
then diluted 1:1 in Optima LC-MS (Fisher) grade ice-cold
MeOH and vortexed briefly again. Next, samples were incubated
at –20◦ C for 30 min, then centrifuged at 4◦ C, 30,130 × g for
10 min to remove remaining solids as previously described
(Nemkov et al., 2017; Reisz et al., 2019). Supernatants were
transferred to pre-cooled autosampler vials, randomized, and
analyzed on a Vanquish UHPLC coupled to a Q Exactive
MS (Thermo Fisher Scientific, San Jose, CA, United States).
Extracts (15 µL) were resolved with flow rate of 300–400
µL/min over an Acuity HSS T3 column (150 × 2.1 mm,
1.8 µm, Waters, Milford, MA, United States) with a 17-min
gradient in negative ion polarity mode as previously described
(Reisz et al., 2019). Samples were introduced to the MS via
electrospray ionization with the MS scanning in full MS mode
over the range of 150–1,500 m/z. As a quality control measure,
technical replicates were injected every six samples to verify
instrument stability (Nemkov et al., 2019). Fatty acids were
annotated and integrated with Maven (Princeton University) in
reference to the KEGG database. Peak quality was validated using

Flow Cytometry
Single cells were prepared from lungs following transcardial
perfusion with PBS as described previously (Clark et al., 2020).
Frontiers in Microbiology | www.frontiersin.org
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13 C

We next considered whether the source or amount of
FAs determined Corynebacterium-mediated inhibition of
S. pneumoniae growth. In the supernatant assays described
above, Corynebacterium cultures were supplemented with the
synthetic surfactant Tween 80 and triolein, a naturally occurring
triacylglycerol. Both Tween 80 and triolein are hydrolyzed by
bacterial enzymes, resulting in the release of oleic acid, which
is used by Corynebacterium as a carbon source for growth
(Plou et al., 1998; Taoka et al., 2011). Triolein is hydrolyzed by
bacterial lipases, while Tween 80 can be hydrolyzed by both
lipases and esterases (Plou et al., 1998). As a result, the bacterial
lipase LipS1 is required for growth of lipophilic C. accolens in
triolein as the sole source of FAs, whereas other enzymes suffice
for growth in Tween 80 (Bomar et al., 2016). To compare the
relative importance of Tween 80 vs. triolein for Corynebacteriummediated inhibition of S. pneumoniae growth, we investigated the
inhibitory capacity of supernatants from Corynebacterium grown
in BHI supplemented with none, one, or both of these lipid
sources. For C. accolens, the addition of Tween 80 to cultures
was sufficient for supernatant inhibition of S. pneumoniae. In
contrast, C. amycolatum inhibition required the addition of both
Tween 80 and triolein (Figure 1E). Titration of the amount of
Corynebacterium supernatants added to culture plates revealed
that at lower concentrations, C. accolens supernatants from
cultures with triolein were more inhibitory than those without
triolein (Supplementary Figure 1B). For C. amycolatum,
triolein was required for inhibition, which only occurred when
supernatants were added above a threshold concentration
(Supplementary Figure 1B). We also confirmed that BHI alone,
supplemented with Tween 80 or Tween 80 and triolein, was not
inhibitory (Supplementary Figure 1B). These results indicate a
dose-dependence for C. accolens and C. amycolatum-mediated
inhibition of S. pneumoniae. In both cases, the inclusion of
triolein increased the inhibitory effect, although the efficiency
of C. amycolatum-mediated inhibition was lower than that of
C. accolens, which was inhibitory in the presence of Tween 80
alone. This difference in substrate usage likely relates to the
composition and expression of bacterial lipases and esterases
responsible for triolein vs. Tween 80 cleavage in C. amycolatum
compared with C. accolens. Therefore, despite the ability of
C. amycolatum to grow without an external source of FAs,
these are required for the inhibitory effect on S. pneumoniae. In
aggregate, these results confirm and extend the importance of FA
release following lipid hydrolysis for Corynebacterium-mediated
inhibition of S. pneumoniae in vitro and identify differential
requirements in distinct Corynebacterium species.

natural isotope abundance

Study Approval
These studies were approved by the Animal Care and Use
Committee (Protocol #00927) and the Institutional Biosafety
Committee (Protocol #1418) of the University of Colorado
School of Medicine.

Statistical Analysis
Graphing and statistical analysis were completed using GraphPad
Prism (Version 8.4.3, GraphPad Software, LLC, San Diego, CA).
Statistical tests included t-tests for single comparisons, ANOVA
with multiple group comparisons of normally distributed data
and Kruskal-Wallis tests with multiple group comparisons of
non-normal (non-Gaussian) distributions of infectious burden
data (due to the limit of detection cut-off). For all statistical tests
p < 0.05 was considered significant. All in vivo infections were
conducted with 3–6 mice per group and repeated 3 times. For
in vitro assays, experiments were completed with 2–3 technical
replicates per condition and repeated 3 times.

RESULTS
Inhibition of S. pneumoniae Growth
in vitro by Lipophilic and Non-lipophilic
Corynebacterium Species
A recent survey of morphologically distinct Corynebacterium
strains collected from infants showed that cell-free supernatants
from four different lipophilic species, including C. accolens,
inhibited S. pneumoniae growth in vitro (Kelly et al., 2021).
However, supernatants from only 20% of the Corynebacterium
isolates tested in this study were inhibitory, indicating that
not all Corynebacterium strains mediate S. pneumoniae growth
restriction in vitro. We considered whether C. amycolatum,
which unlike C. accolens does not require exogenous FAs for
either growth or mycolic acid production, inhibits S. pneumoniae
growth in vitro. Cell-free supernatants from C. accolens
or C. amycolatum were spread onto culture plates prior
to S. pneumoniae inoculation, and S. pneumoniae colony
forming units (CFUs) were determined following overnight
incubation (Figure 1A). In contrast to robust growth of type
2 S. pneumoniae (strain D39) on untreated culture plates, no
growth of S. pneumoniae was detected on plates pre-treated
with supernatants from either C. accolens or C. amycolatum
(Figure 1B and Supplementary Figure 1A). S. pneumoniae
growth was also not detected on plates treated with oleic
acid, a FA that kills S. pneumoniae (Clementi et al., 2013),
included as a positive control. Supernatants from both C. accolens
and C. amycolatum demonstrated similar inhibition of type 4
and type 3 S. pneumoniae strains (Figures 1C,D), indicating
that multiple serotypes of S. pneumoniae are vulnerable to
C. accolens and C. amycolatum-mediated growth restriction.
Thus, both C. accolens and the non-lipophilic C. amycolatum
inhibit S. pneumoniae growth in vitro.

Frontiers in Microbiology | www.frontiersin.org

Corynebacterium Species Colonize the
Upper and Lower Airway of Antibiotic
Treated Mice
In order to investigate whether Corynebacterium species mediate
inhibition of S. pneumoniae in vivo, we first established a model
of short-term Corynebacterium colonization. Mice were treated
for 1 week with water containing an antibiotic cocktail to
reduce the endogenous flora. One week of antibiotic treatment
significantly decreased the total microbial burden in both
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FIGURE 1 | Inhibition of S. pneumoniae growth in vitro by lipophilic and non-lipophilic Corynebacterium species. Supernatant inhibition assay schematic using tryptic
soy broth (TSB), neomycin (Neo), and catalase plates (A). Growth of type 2 S. pneumoniae (Spn), (B), type 4 Spn (C), and type 3 Spn (D) on untreated plates (–) or
on plates pre-treated with supernatants from C. accolens (C. acc) or C. amycolatum (C. amy) or with 180 mg/mL oleic acid. Growth of type 2 Spn on untreated
plates (–) or on plates pre-treated with supernatants from C. acc or C. amy grown in BHI with or without 1% Tween 80 and 180 mg/mL triolein (E). Limit of detection
(LOD) is indicated. Data are pooled from three independent experiments in duplicate. ***p < 0.001, ANOVA.

supporting Corynebacterium growth. However, Corynebacterium
colonization did not significantly alter the relative abundances
of any of the FAs detected (Figure 2C). These data suggest
that either short-term colonization is not sufficient to alter
the FA landscape, or that FA turnover by host or bacterial
metabolic processes obscured any temporal changes. This
model for short-term Corynebacterium colonization of the
murine airway provided the opportunity to characterize the
physiologic and pathologic impact of these commensals on
pneumococcal infection.

the upper airway and gut (Supplementary Figure 2). Mice
were taken off antibiotics 2 days prior to intranasal (i.n.)
infection with C. accolens, C. amycolatum, or PBS (control),
and Corynebacterium burdens were determined 2 days following
infection (Figure 2A). Both C. accolens and C. amycolatum
were detected in the upper airway (nasal lavage) and lungs
of mice 48 h post-infection as measured by live CFU counts
from nasal lavage fluid and homogenized lung tissue of mice
infected with Corynebacterium species, but not PBS-treated
controls (Figure 2B). Both sites were successfully colonized,
albeit with generally higher numbers in the lungs than in the
upper airway. These data indicate that both lipophilic and nonlipophilic Corynebacterium species can successfully colonize the
airway of antibiotic-treated mice. In order to determine the
availability of FAs in the murine upper airway, as well as
whether Corynebacterium colonization influenced FA content,
nasal lavage fluids were analyzed by mass spectrometry (MS).
Several FAs were detected in the nasal lavage fluid, including
oleic acid, myristic acid, and palmitoleic acid (Figure 2C),
all of which are also present in human nasal lavage fluid
(Do et al., 2008). These data are consistent with the presence
of FAs in the upper airway of mice which are capable of
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Inflammatory Myeloid Cells Are
Recruited to the Lungs of
Corynebacterium-Colonized Mice
We next interrogated the impact of short-term Corynebacterium
colonization on local and systemic cytokine production as well as
the recruitment of inflammatory myeloid cells to the lung. Both
C. accolens and C. amycolatum induced a significant increase
in systemic levels of the pro-inflammatory cytokines TNFα
and IFNγ, compared with PBS-treated mice (Figure 3A). In
the lung, however, we found that Corynebacterium colonization
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FIGURE 2 | Corynebacterium species colonize the upper and lower airway of antibiotic treated mice. Timeline for antibiotic treatment followed by infection with
C. acc or C. amy (A). Burden of Corynebacterium (Coryneb) in the nasal lavage fluid and lungs of mice 48 h post-infection with C. acc, C. amy, or PBS (–) detected
by live growth (B). Relative abundance of fatty acids detected in the nasal lavage fluid of naïve mice and mice 48 h post-infection with C. acc or C. amy (C). Data are
pooled from three independent experiments with 3–6 mice per group. No significant differences detected in relative FA abundances between groups, ANOVA.
*p < 0.05, **p < 0.01, ***p < 0.001, Kruskal-Wallis test.

(AMs, CD45+ SiglecF+ CD11blow CD11c+ cells), compared
with PBS treated controls (Figure 3E). Unlike neutrophils
and inflammatory monocytes, AMs are largely self-renewing
locally in the lung. As the first immune cell to encounter
inhaled particles, AMs frequently undergo cell death following
bacterial uptake (FitzGerald et al., 2020), consistent with our
observation of reduced AMs in the lungs of Corynebacterium
infected mice. We detected no changes in CD103+ dendritic
cells (DCs, CD45+ MHCII+ SiglecF− CD11c+ CD64− cells) or
CD11bhi DCs, or the expression of MHCII in either population
as an indicator of activation, in Corynebacterium-infected
mice compared with PBS-treated controls (Supplementary
Figure 4). Collectively, these data indicate that Corynebacterium
colonization is associated with selective mucosal responses,
including increased chemokine-associated myeloid cell
recruitment to the lung but minimal changes to the local
pro-inflammatory cytokine landscape.

had little impact on cytokine expression in the bronchoalveolar
lavage fluid (BAL) at 48 h post-infection, as measured by
a 13-plex inflammatory cytokine/chemokine array. Of the
13 cytokines and chemokines tested, only MCP-1 (CCL2),
an important chemokine for monocyte and macrophage
recruitment (Gschwandtner et al., 2019), was significantly
upregulated in the BAL of C. accolens and C. amycolatumcolonized mice (Figure 3B and not shown). These findings
indicate that Corynebacterium colonization is associated with
increased circulating pro-inflammatory cytokines, but a minimal
such response in the lung.
We determined the impact of Corynebacterium colonization
on lung innate immune cell populations by flow cytometry (see
gating strategy, Supplementary Figure 3). Corynebacterium
colonization was associated with an increase of both neutrophils
(CD45+ Ly6G+ CD11b+ cells) and inflammatory monocytes
(CD45+ Ly6G− Ly6C+ CD11b+ cells) in the lung (Figures 3C,D).
These increases parallel the elevated MCP-1, which mobilizes
the recruitment of inflammatory monocytes from the bone
marrow (Gschwandtner et al., 2019), detected in the BAL of
Corynebacterium-infected mice. Neutrophils are also recruited
to the lung from the bone marrow, though responses to other
chemokines such as MIP-1 (CXCL2) (Lin and Fessler, 2021) were
not measured here. In contrast, the lungs of mice infected with
C. accolens or C. amycolatum had reduced alveolar macrophages
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Colonization With Corynebacterium
Inhibits Colonization and Infection With
S. pneumoniae in vivo
Our goal in establishing a model for Corynebacterium
colonization was to evaluate whether Corynebacterium
species inhibit the acquisition and growth of S. pneumoniae
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FIGURE 3 | Inflammatory myeloid cells are recruited to the lungs of Corynebacterium-colonized mice. Systemic TNFα and IFNγ detected in mice 48 h post-infection
with C. acc, C. amy, or PBS (–) (A). Cytokines and chemokines detected in lung BAL in mice 48 h post-infection with C. acc or C. amy (B), with significance
indicated relative to mice pre-exposed to PBS (none). Percentage and total number of neutrophils (CD45+ SiglecF− Ly6G+ CD11b+ cells) (C), inflammatory
monocytes (CD45+ Ly6G− Ly6C+ CD11b+ cells) (D), and alveolar macrophages (AMs, CD45+ SiglecF+ CD11blow CD11c+ cells) (E) detected by flow cytometry in
the lungs of mice 48 h post-infection with C. acc, C. amy, or PBS (–). Data are pooled from three independent experiments with 3–6 mice per group. *p < 0.05,
**p < 0.01, ***p < 0.001, ANOVA.

airway, and S. pneumoniae was not detected in the lungs of
50–60% of the animals in each Corynebacterium exposure
group. C. accolens and C. amycolatum burdens remained
detectable following growth in non-selective media in the
majority of co-infected mice at this timepoint (Figure 4C).
Further, mice with the highest Corynebacterium burdens
had the lowest, frequently undetectable, S. pneumoniae
burdens in the lung (Supplementary Figures 5A,B).
Our data are consistent with longitudinal microbiome
sequencing studies which suggest that Corynebacterium
abundance predicts S. pneumoniae acquisition and infection
risk in children (Biesbroek et al., 2014; Teo et al., 2015;

in vivo, similar to Corynebacterium-mediated inhibition of
S. pneumoniae observed by our group and others in vitro. We
exposed antibiotic-treated mice to C. accolens or C. amycolatum
1 day prior to intranasal infection with streptomycin-resistant
type 2 S. pneumoniae and plated nasal lavage contents and
lung homogenates on selective media containing streptomycin
1 day later (Figure 4A). Compared with mice pre-exposed to
PBS, colonization with either C. accolens or C. amycolatum
significantly reduced the burden of S. pneumoniae in both
the upper airway (nasal lavage) and lung by 24 h postinfection (Figure 4B). In mice pre-exposed to Corynebacterium,
S. pneumoniae burdens were reduced by ∼1 log in the upper
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FIGURE 4 | Colonization with Corynebacterium inhibits colonization and infection with S. pneumoniae in vivo. Timeline for antibiotic treatment followed by
pre-exposure to PBS (–), C. acc or C. amy prior to infection with S. pneumoniae (Spn) (A). Burden of Spn (B) or Corynebacterium (Coryneb) (C) in nasal lavage fluid
and lungs of mice pre-exposed to PBS (–), C. acc or C. amy at 24 h post-Spn infection detected by live growth. Limit of detection (LOD) is indicated. Data are
pooled from three independent experiments with 3–5 mice per group. ***p < 0.001, Kruskal-Wallis test.

immune response but may also facilitate pneumococcal
dissemination (Rosendahl et al., 2013), remained the same,
although CD103+ DC expression of the activation marker
MHCII was significantly reduced in Corynebacterium coinfected mice compared to mice infected with S. pneumoniae
alone (Supplementary Figure 6). The reduction in inflammatory
myeloid cells together with the recovery of AMs, which are
important for the resolution of inflammation in the lung, is
consistent with a pro-resolving immune response in the lungs
of co-infected mice. We conclude that colonization with either
C. accolens or C. amycolatum improves early clearance of
S. pneumoniae from the upper and lower airways of mice, in
association with reduced, rather than enhanced, inflammation in
the lung, likely limiting lung injury.

Bosch et al., 2017; Kelly et al., 2021). Of particular note, these
studies demonstrate the potential for live animal modeling
of Corynebacterium-S. pneumoniae dynamics in vivo in
order to elucidate the bacterial and host requirements for
Corynebacterium-mediated protection against respiratory
tract infection.

Reduced Inflammation and Inflammatory
Myeloid Cell Recruitment in the Lungs of
Corynebacterium-S. pneumoniae
Co-infected Mice
Corynebacterium co-infected mice also had a reduced
inflammatory response in the lung compared to mice infected
with S. pneumoniae alone. In contrast to S. pneumoniae
challenged mice pre-exposed to PBS, systemic TNFα and
IFNγ were reduced in mice pre-exposed to C. accolens or
C. amycolatum (Figure 5A). Similarly, in the BAL of co-infected
mice, levels of several pro-inflammatory cytokines including
TNFα, IFNγ, and IL-6 as well as the chemokine MCP-1 were
reduced in mice pre-exposed to Corynebacterium compared to
mice infected with S. pneumoniae alone (Figure 5B), while 9
other cytokines were not affected (not shown). Total neutrophils
and inflammatory monocytes in the lungs of co-infected
mice were also reduced compared with mice infected with
S. pneumoniae alone (Figures 5C,D). In contrast, AMs were
increased in co-infected mice (Figure 5E). Overall populations
of lung DCs, which are important for mobilizing the adaptive
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Corynebacterium Lipases Contribute to,
but Are Not Required for, Protection
Against S. pneumoniae in vivo
We next sought to confirm the importance of the lipase LipS1 for
C. accolens-mediated inhibition of S. pneumoniae growth in vitro
and to determine whether C. amycolatum expresses a lipase with
similar activity. We first constructed a lipS1 mutant in our strain
of C. accolens by in-frame gene deletion. As described for the
original 1lipS1 C. accolens, our 1lipS1 C. accolens grew poorly in
triolein as the sole source of FAs (Bomar et al., 2016), indicating
LipS1 as critical for lipase-mediated hydrolysis and growth in
C. accolens (Supplementary Figure 7A). In contrast, growth of
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FIGURE 5 | Reduced inflammation and inflammatory myeloid cell recruitment in the lungs of Corynebacterium-S. pneumoniae co-infected mice. Systemic TNFα and
IFNγ detected in mice pre-exposed to PBS (–), C. acc or C. amy at 24 h post-S. pneumoniae (Spn) infection (A). Cytokines and chemokines detected in lung BAL in
mice pre-exposed to PBS (–), C. acc or C. amy at 24 h post-Spn infection (B), significance indicated relative to mice pre-exposed to PBS (none). Percentage and
total number of neutrophils (C), inflammatory monocytes (D), and alveolar macrophages (AMs) (E) detected by flow cytometry in the lungs of mice pre-exposed to
PBS (–), C. acc or C. amy at 24 h post-Spn infection. Data are pooled from three independent experiments with 3–5 mice per group. **p < 0.01, ***p < 0.001,
ANOVA.

1lipS1 C. accolens in Tween 80 was not impaired relative to wildtype (WT) C. accolens, presumably due to the hydrolysis of Tween
80 by bacterial esterases.
Bacterial lipases in both C. accolens and C. amycolatum
are essential for Corynebacterium-mediated inhibition of
S. pneumoniae growth in vitro but have distinct characteristics.
Supernatants from 1lipS1 C. accolens did not inhibit
S. pneumoniae growth in vitro, whereas those from WT
C. accolens did (Figure 6A), confirming the importance of
LipS1 for S. pneumoniae inhibition in vitro. A search for
similar bacterial lipases in C. amycolatum in the NCBI database
identified the protein WP_005510233.1 as sharing the greatest
homology with that of C. accolens LipS1 (WP_005285206.1).
Though overall protein sequence homology to C. accolens LipS1
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was low (36%), the NCBI Conserved Domain Database (CDD,
version cdd.v.3.19) (Lu et al., 2019) classified WP_005510233.1
as a member of the LIP family of secretory lipases with an
E-value of 2.94e−33 , similar to C. accolens LipS1. C. amycolatum
WP_005510233.1 also contains the lipase motif G-X-S-XG with a predicted active site serine residue (Jaeger et al.,
1994), a shared feature among bacterial lipases. Analysis
using the SignalP program (version 5.0) (Petersen et al., 2011)
indicated that while both C. accolens LipS1 and C. amycolatum
WP_005510233.1 are predicted to be secreted by the general
secretion pathway (Sec), LipS1 contains an SP1 cleavage site,
whereas C. amycolatum WP_005510233.1 contains an SPII
cleavage site. Based on this analysis, we generated an in-frame
deletion of WP_005510233.1 in C. amycolatum, referred to
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FIGURE 6 | Corynebacterium lipases contribute to, but are not required for, protection against S. pneumoniae in vivo. Growth of type 2 S. pneumoniae (Spn) on
untreated plates (–) or on plates pre-treated with supernatants from WT vs. 1lipS1 C. acc or WT vs. 1lip C. amy grown in BHI with 1% Tween 80 and 180 mg/mL
triolein (A). Burden of Spn (B) or Corynebacterium (Coryneb) (C) in nasal lavage fluid and lungs of mice pre-exposed to PBS (–), WT C. acc or 1lipS1 C. acc at 24 h
post-Spn infection detected by live growth. Limit of detection (LOD) is indicated. Data are pooled from three independent experiments with 3–5 mice per group.
*p < 0.05, **p < 0.01, ***p < 0.001, ANOVA (A) or Kruskal-Wallis test (B,C).

as 1lip C. amycolatum, to determine whether this putative
lipase contributes to C. amycolatum-mediated inhibition of
S. pneumoniae growth. As C. amycolatum is non-lipophilic,
1lip C. amycolatum grew similarly to WT in either Tween 80
or triolein (Supplementary Figure 7B). However, supernatant
from 1lip C. amycolatum no longer inhibited S. pneumoniae
growth in vitro (Figure 6A), suggesting that this lipase is critical
for C. amycolatum-mediated inhibition in vitro.
Lipases such as LipS1 and/or other bacterial factors may
contribute to Corynebacterium-mediated protection against
S. pneumoniae in vivo. Using our co-infection animal model,
we compared the impact of pre-exposure to WT vs. 1lipS1
C. accolens on S. pneumoniae colonization and infection.
S. pneumoniae burdens in the upper airway (nasal lavage) were
higher in mice pre-exposed to 1lipS1 C. accolens compared to
mice pre-exposed to WT C. accolens (Figure 6B). However, there
was still a significant reduction in upper airway S. pneumoniae
burdens in mice pre-exposed to 1lipS1 C. accolens compared
to mice infected with S. pneumoniae alone. These findings
indicate that C. accolens expression of LipS1 contributes to,
but is not solely required for, inhibition of S. pneumoniae
colonization in the upper airway. In the lungs, mice preexposed to either 1lipS1 or WT C. accolens had significantly
reduced burdens of S. pneumoniae compared with mice infected
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with S. pneumoniae alone (Figure 6B). There was a slight
increase in the percentage of mice with detectable S. pneumoniae
burdens in the lung following pre-exposure to 1lipS1 C.
accolens (38%) vs. WT C. accolens (15%), similar to the upper
airway, however, this difference was not statistically significant.
Burdens of WT and 1lipS1 C. accolens in the nasal lavage
and lungs of co-infected mice were similar (Figure 6C),
indicating no colonization defect for 1lipS1 C. accolens. Also,
mice with the highest burdens of either WT or 1lipS1 C.
accolens correlated with lower and frequently undetectable
burdens of S. pneumoniae in the lung (Supplementary
Figure 5C), confirming a relationship between C. accolens
abundance and reduced S. pneumoniae infection of the lung.
These data indicate that multiple mechanisms, both LipS1dependent and independent, contribute to Corynebacteriummediated protection against S. pneumoniae in vivo.

DISCUSSION
Our findings provide novel evidence in support of the potential
benefit of Corynebacterium abundance in the airway. Both
C. accolens and C. amycolatum inhibited S. pneumoniae growth
in vitro, observations corroborated by protection in vivo
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with other airway commensals (Liu et al., 2019). Finally,
Corynebacterium-mediated recruitment of inflammatory
myeloid cells, as we observed in the lung, may serve as an
immune priming signal to enhance clearance of S. pneumoniae,
as neutrophils and inflammatory monocytes are critical for early
S. pneumoniae killing (Calbo and Garau, 2010). The development
of an animal model for Corynebacterium colonization, which
mirrors the relationship between Corynebacterium abundance
and risk of S. pneumoniae acquisition observed in humans,
should facilitate investigation of these and other mechanisms
in future studies. However, translation of such findings in
mice into novel therapeutic approaches will require verification
that similar effects are active during human colonization with
Corynebacterium.
In these studies, two morphologically and metabolically
distinct species of Corynebacterium protected against
S. pneumoniae growth. The non-lipophilic C. amycolatum
was only inhibitory in vitro upon the addition of multiple
FA sources, indicating that screens which do not incorporate
enough exogenous lipids may miss the inhibitory potential of
additional Corynebacterium clinical isolates. Indeed, while airway
microbiome sequencing studies indicate a broadly protective
role for Corynebacterium species against respiratory tract
infections and S. pneumoniae, mechanistic studies have revealed
heterogeneity among different Corynebacterium-pathogen pairs.
For example, both C. pseudodiphtheriticum and Corynebacterium
striatum inhibit growth of the pathogen S. aureus, whereas
C. accolens instead promotes S. aureus growth in vitro (Yan et al.,
2013; Ramsey et al., 2016). C. pseudodiphtheriticum mediates
a broadly protective effect against primary and secondary
S. pneumoniae infections (Kanmani et al., 2017; Moyano et al.,
2020) and also inhibits growth of another pathogen, Moraxella
catarrhalis, in vitro (Lappan and Peacock, 2019). The potential
therapeutic effect of C. pseudodiphtheriticum has been evaluated
in humans, where delivery by nasal spray was shown to reduce
colonization with S. aureus in healthy adults (Kiryukhina et al.,
2013). While this was only tested in four subjects, another
Corynebacterium designated as strain Co304 had a similar effect
in another 17 subjects (Uehara et al., 2000). The impact of other
Corynebacterium species, including those such as C. accolens
which may inhibit some pathogens but promote others, on
a broader infection profile will be important to determine
in future studies.
Colonization of mice by both species of Corynebacterium
(C. accolens and C. amycolatum) elicited comparably robust
myeloid cell responses in the lung in parallel with elevations
in the chemotactic protein MCP-1. However, neither species
induced appreciable expression of pro-inflammatory cytokines
in lung BAL. As reported following colonization with
C. pseudodiphtheriticum in infant mice (Kanmani et al., 2017),
both TNFα and IFNγ were increased in the serum, as in our
study, but, unlike our results, several pro-inflammatory cytokines
were also increased in the BAL, highlighting the importance
of investigating species-specific outcomes. Colonization at
different host sites may also induce distinct immune activation
profiles. We did not detect an IL-17A response in the lungs of
Corynebacterium-exposed mice, whereas skin colonization with

using a new co-infection model. The only mechanism for
Corynebacterium-mediated protection against S. pneumoniae
described thus far is the liberation of host FAs by LipS1 in
C. accolens (Bomar et al., 2016), as confirmed herein both
in vitro and in vivo. Beyond direct killing of S. pneumoniae,
FAs induce expression of the antimicrobial peptide β-defensin-2
by human sebocytes (Nakatsuji et al., 2010), which may further
enhance protection against S. pneumoniae in the airway. We
demonstrate that FAs are present in the upper airway of mice,
as in humans (Do et al., 2008), consistent with their availability
to serve as a nutrient source for lipophilic Corynebacterium such
as C. accolens. The finding that Corynebacterium colonization
did not influence FA abundance may result from a lack
of accessible triacylglycerols for FA production, as has been
suggested (Bomar et al., 2016), metabolic turnover, or temporal
fluctuations which were missed. Alternatively, we did not
determine whether the expression of LipS1 is upregulated
in co-infected mice. Regardless, the observation that LipS1deficient C. accolens is less protective against S. pneumoniae
suggests that lipase activity contributes to S. pneumoniae
killing in vivo. Others have confirmed that the mouse airway
can be colonized with endogenous Corynebacterium, which
becomes the dominant genus following treatment with the
antibiotic neomycin (Ichinohe et al., 2011). This finding
indicates that competition with the resident microbiota limits
Corynebacterium colonization, consistent with our inability to
establish Corynebacterium colonization in non-antibiotic-treated
mice (not shown). Thus, while host lipids, including FAs, are
present in the mouse airway, microbial depletion is likely a
requirement for modeling Corynebacterium colonization.
The partial protective effect of LipS1-deficient C. accolens
indicates a role for additional mechanisms of Corynebacteriummediated protection in vivo. S. pneumoniae and other
opportunistic pathogens are enriched following antibiotic
therapy in children, whereas Corynebacterium are reduced (Teo
et al., 2015; Kelly et al., 2021), suggesting that S. pneumoniae is
better equipped for expansion into the microbiome-depleted
airway. We found that colonizing mice with Corynebacterium
prior to S. pneumoniae exposure is sufficient to reverse this
expansion. In addition to competition with pathogens through
the expression of bacterial lipases, some Corynebacterium
species produce siderophores, which reduce growth of the
pathogen Staphylococcus aureus in iron-limiting environments
(Stubbendieck et al., 2019), although the potential impact on
S. pneumoniae is not known. Beyond competition for niche
space and nutrients, interactions between Corynebacterium and
airway epithelial cells may contribute to enhanced protection
against S. pneumoniae in vivo. For example, some species
of Corynebacterium express the molecule phosphorylcholine
(ChoP) (Gillespie et al., 1996), which binds to platelet activating
factor receptor (PAFR), a critical adherence receptor for
S. pneumoniae (Rijneveld et al., 2004). ChoP expression by
selected Corynebacterium species may therefore interfere
with S. pneumoniae access to PAFR, reducing S. pneumoniae
acquisition and infection. Moreover, Corynebacterium activation
of airway epithelial cells may enhance their production
of antimicrobial peptides in a FA-independent manner, as
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C. accolens, but not C. amycolatum, was associated with the
induction of a γδT cell IL-17A response (Ridaura et al., 2018).
The lung is particularly sensitive to the detrimental effects of
inflammation, which causes damage to the integrity of the
barrier, reducing oxygen exchange (Muller-Redetzky et al., 2014).
S. pneumoniae co-infections, particularly with viral pathogens,
are associated with an enhanced inflammatory response,
promoting inflammation-mediated damage in the co-infected
lung and leading to increased morbidity and mortality (Kash
et al., 2011; Aguilera and Lenz, 2020). In contrast, we find that,
unlike with respiratory viral and other pathogens, co-infection
with Corynebacterium tempers the inflammatory response to
S. pneumoniae, as described for C. pseudodiphtheriticum in the
context of sterile lung injury (Kanmani et al., 2017; Moyano
et al., 2020), along with S. pneumoniae clearance, indicating the
potential to improve lung recovery from infection and injury.
A limitation of this study is that we did not investigate cocolonization with Dolosigranulum, which frequently associates
with Corynebacterium in the human upper airway of humans
(Bogaert et al., 2011; Laufer et al., 2011; Copeland et al., 2018).
Abundances of several different Corynebacterium species are
increased in both child and adult carriers of Dolosigranulum
(Brugger et al., 2020). In vitro, these authors demonstrated
that some Corynebacterium species support growth of
Dolosigranulum pigrum, although not consistently (Brugger
et al., 2020). Further, S. pneumoniae growth was inhibited in vitro
by D. pigrum and C. pseudodiphtheriticum, neither of which were
inhibitory on their own under the assay conditions used (Brugger
et al., 2020). This study alludes to greater complexity in the
human airway, where Corynebacterium-pathogen interactions
are likely influenced by the presence of other commensal species
including Dolosigranulum. In addition, Corynebacterium and
Dolosigranulum must themselves compete with other airway
commensals. For example, Staphylococcus epidermidis can
inhibit both D. pilgrim and C. pseudodiphtheriticum growth
in vitro (Janek et al., 2016). These findings highlight the
importance of considering multiple commensal-pathogen
dynamics in the airway, beyond interactions between specific
commensal-pathogen pairs.
In summary, these studies identify C. accolens and
C. amycolatum as Corynebacterium species which are capable
of short-term colonization in antibiotic treated mice. Further,
pre-exposure to either of these Corynebacterium species
significantly reduces S. pneumoniae infection while mitigating
lung inflammation. Although the host and bacterial requirements
for Corynebacterium-mediated protection against S. pneumoniae
are not fully resolved, both C. accolens and C. amycolatum
express bacterial lipases which contribute to growth inhibition
in vitro, a mechanism responsible, in part, for C. accolensmediated protection in vivo. These findings indicate that
therapeutic strategies to enhance Corynebacterium colonization
may reduce the risk of S. pneumoniae acquisition and infection.
We envision that such approaches would be particularly
beneficial following antibiotic therapy, when the endogenous
airway microbiome is disrupted. However, it is also important
to consider potential adverse effects associated with enhanced
Corynebacterium colonization, as some species may serve as a
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source of opportunistic infections. Improved understanding of
the mechanisms of Corynebacterium-mediated protection will
therefore facilitate harnessing the potential therapeutic benefit of
these endogenous “protector” bacteria.
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